Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 33.15 is 20% below its 5-year average of 41.59, around the middle of its 5-year range (11.13–84.05).
As of the fiscal period ended Tuesday, June 30, 2026. 2.57% below its 12-month average of 34.03.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 33.15.
QUICK RATIO (ACID-TEST)
33.15
QUICK RATIO (ACID-TEST) AVG TTM
34.03
QUICK RATIO (ACID-TEST) AVG 3Y
28.02
QUICK RATIO (ACID-TEST) AVG 5Y
41.59
QUICK RATIO (ACID-TEST) AVG 10Y
29.85
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-2.57%
CURRENT VS 3Y AVG
+18.30%
CURRENT VS 5Y AVG
-20.29%
CURRENT VS 10Y AVG
+11.07%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
+888.14%
vs the sector median at left
XBiotech Inc.
Market Cap
$65.85M
Quick Ratio (Acid-Test)
33.15
TTM Avg
34.03
3Y Avg
28.02
5Y Avg
41.59
Market Cap
$65.86M
Quick Ratio (Acid-Test)
3.50
TTM Avg
1.85
3Y Avg
1.22
5Y Avg
3.58
Market Cap
$65.87M
Quick Ratio (Acid-Test)
0.53
TTM Avg
4.76
3Y Avg
5.20
5Y Avg
7.10
Market Cap
$64.18M
Quick Ratio (Acid-Test)
0.27
TTM Avg
0.22
3Y Avg
0.21
5Y Avg
0.99
Market Cap
$63.78M
Quick Ratio (Acid-Test)
9.90
TTM Avg
11.46
3Y Avg
13.71
5Y Avg
15.39
Market Cap
$68.10M
Quick Ratio (Acid-Test)
3.83
TTM Avg
1.68
3Y Avg
1.58
5Y Avg
2.46
Market Cap
$63.02M
Quick Ratio (Acid-Test)
0.97
TTM Avg
1.07
3Y Avg
1.19
5Y Avg
1.33
Market Cap
$68.90M
Quick Ratio (Acid-Test)
6.12
TTM Avg
4.89
3Y Avg
4.64
5Y Avg
6.12
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| XBiotech Inc. (XBIT) | $65.85M | 33.15 | 34.03 | 28.02 | 41.59 |
| Cingulate Inc. (CING)vs › | $65.86M | 3.50 | 1.85 | 1.22 | 3.58 |
| Gossamer Bio, Inc. (GOSS)vs › | $65.87M | 0.53 | 4.76 | 5.20 | 7.10 |
| iBio, Inc. (IBIO)vs › | $67.52M | 7.85 | 4.72 | 3.68 | 5.30 |
| Alps Group Inc (ALPS)vs › | $64.18M | 0.27 | 0.22 | 0.21 | 0.99 |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | 9.90 | 11.46 | 13.71 | 15.39 |
| Fortress Biotech, Inc. (FBIO)vs › | $68.10M | 3.83 | 1.68 | 1.58 | 2.46 |
| InterCure Ltd. (INCR)vs › | $63.02M | 0.97 | 1.07 | 1.19 | 1.33 |
| Spero Therapeutics, Inc. (SPRO)vs › | $68.90M | 6.12 | 4.89 | 4.64 | 6.12 |
| Heron Therapeutics, Inc. (HRTX)vs › | $62.78M | 1.51 | 1.60 | 1.72 | 2.07 |
Quick Ratio
33.15
Excludes inventory
Current Ratio
33.15
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 33.15 |
| 2026-03-31 | 39.03 |
| 2025-12-31 | 16.01 |
| 2025-09-30 | 41.78 |
| 2025-06-30 | 40.16 |
| 2025-03-31 | 29.15 |
| 2024-12-31 | 11.56 |
| 2024-09-30 | 11.57 |
| 2024-06-30 | 11.13 |
| 2024-03-31 | 12.03 |
| 2023-12-31 | 33.07 |
| 2023-09-30 | 38.61 |
| 2023-06-30 | 47.08 |
| 2023-03-31 | 59.78 |
| 2022-12-31 | 54.07 |
| 2022-09-30 | 62.44 |
| 2022-06-30 | 28.99 |
| 2022-03-31 | 84.05 |
| 2021-12-31 | 71.49 |
| 2021-09-30 | 64.81 |
| 2021-06-30 | 83.49 |
| 2021-03-31 | 120.51 |
| 2020-12-31 | 81.80 |
| 2020-09-30 | 40.61 |
| 2020-06-30 | 18.28 |
| 2020-03-31 | 25.20 |
| 2019-12-31 | 11.90 |
| 2019-09-30 | 20.24 |
| 2019-06-30 | 18.52 |
| 2019-03-31 | 4.57 |
| 2018-12-31 | 5.78 |
| 2018-09-30 | 9.26 |
| 2018-06-30 | 9.35 |
| 2018-03-31 | 12.22 |
| 2017-12-31 | 11.94 |
| 2017-11-02 | 11.50 |
| 2017-06-30 | 10.14 |
| 2017-03-31 | 10.72 |
| 2016-12-31 | 4.64 |
| 2016-09-30 | 7.35 |
| 2016-06-30 | 6.39 |
| 2016-03-31 | 12.17 |
| 2015-12-31 | 14.79 |
| 2015-09-30 | 21.70 |
| 2015-06-30 | 42.01 |
| 2015-03-31 | 14.05 |
| 2014-12-31 | 18.45 |
| 2014-09-30 | 6.50 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.00 |
| 2013-12-31 | 9.10 |